Hi [[ session.user.profile.firstName ]]
Sort by:
    • The State of Patent Eligibility
      The State of Patent Eligibility Managing IP and Lexis Nexis Recorded: Sep 19 2012 3:00 pm UTC 83 mins
    • After the Supreme Court’s decision in Prometheus and its vacatur and remand of the Myriad decision, the question of what constitutes patent eligible subject matter continues to pose a challenge to courts, the PTO and practitioners. This webinar will address the impact of the Prometheus decision on the eligibility question including what guidance it may provide with respect to the eligibility of gene patents, how the PTO is likely to react to the decision and the impact the decision will have on the medical field.

      Read more >
    • Part 2: Six Steps to a Solid Mobility Policy in 2014
      Part 2: Six Steps to a Solid Mobility Policy in 2014 Richard Absalom, Analyst with Ovum Recorded: Feb 6 2014 8:05 pm UTC 59 mins
    • In Part 1, we shared key trends to watch and consider as you build your mobile plan for 2014. In this session, we take a deeper dive to help you develop your company's mobile policy to fully embrace the BYOD trend, enable employees to be productive on any device they choose, and keep corporate data secure.

      Watch Ovum analyst, Richard Absalom, as he outlines Ovum's 6 recommended areas to consider when building a mobility policy:

      - Security: Safeguarding corporate-sensitive data
      - Employee privacy: Defining clear boundaries between monitoring corporate and personal usage
      - Eligibility: Identifying which employees are suitable for your policy
      - Acceptable use and dealing with policy violations: Educating users to comply with policy regulations
      - Technical support: Determining responsibility for dealing with device malfunctions
      - Reimbursement and total cost of ownership: Drawing the line for corporate expenses

      Read more >
    • Early access for patients with unmet medical needs
      Early access for patients with unmet medical needs David Fisher, Paul Ledger, Mark Corbett Recorded: Dec 4 2013 2:00 pm UTC 63 mins
    • Many patients around the world struggle to gain access to new therapeutic options. There may be no clinical trials in close proximity or the eligibility requirements are too limiting. In some cases the wait for approval may simply be too long.

      In such cases a Global Access Program can be an effective way to ensure the medicine reaches the patient. These programs (also referred to as expanded access, compassionate use and named patient programs) follow ethical and regulatory-compliant mechanisms, enabling patients to gain access to medicines that are in clinical development, are unlicensed in a specific market but licensed elsewhere, or are still going through the marketing authorization application (MAA) process.

      These programs afford companies the opportunity to meet ethical obligations, offering physicians and patients potentially life-saving or life-extending treatment options, ahead of commercial availability. In addition, Global Access Programs can assist in helping foster positive relationships with key opinion leaders and treatment centres, as well as providing an opportunity to gather limited, yet valuable, information about the use of a drug in a wider population.

      This free webinar will provide an overview of Global Access Programs and the current regulatory environment, describe best practices for implementation and present a case study detailing use of such programs to help patients with unmet medical needs.

      Please join us on December 4, 3pm Europe, 2pm UK time.

      Confirmed speakers:

      - Paul Ledger, Head of Commercialisation for EMAP Rare Disease for GSK
      - Mark Corbett, Senior Vice President, Clinigen Global Access Programs (GAP)

      Read more >
    • ACM Live: IBM, David Caldeira
      ACM Live: IBM, David Caldeira David Caldeira Recorded: Jun 25 2013 7:15 pm UTC 18 mins
    • The Texas Office of the Attorney General’s Crime Victim Services Division provides victims of violent crimes a means to apply for eligibility for the Crime Victims’ Compensation Program, which pays medical and other bills related to the crime.
      Dated system was close to failure, which would have negatively impacted victim’s claim processing as well as legislative mandated measures, putting federal funding in jeopardy.
      Work unpredictability was burdensome to existing system of manual processes.

      Implementation & Innovation
      Initiates pre-defined and ad hoc tasks, with email or workflow notifications supporting work unpredictability
      Provides for improved reporting, content analytics and trend analyses relative to the nature of the crime victim services required
      Starts cases without all required information, allowing the jumpstart of an investigation
      Leverages business rules to drive the assignment of cases, including staff availability, case type, and degree of relatedness

      Enhances the speed and quality of case outcomes by tailoring work to the way Knowledge Workers worked
      Improves allocation and utilization of resources because the system provides a 360 degree view of the work processes and workload status
      Offers better reliability, security and lower long term operating cost through cloud-hosting
      Platform approach lends itself to next phases: mainframe replacement and social networking

      IBM Business Partner – Adjacent Technologies Inc.
      IBM Case Manager platform

      Read more >